CL2009000920A1 - Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations. - Google Patents

Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.

Info

Publication number
CL2009000920A1
CL2009000920A1 CL2009000920A CL2009000920A CL2009000920A1 CL 2009000920 A1 CL2009000920 A1 CL 2009000920A1 CL 2009000920 A CL2009000920 A CL 2009000920A CL 2009000920 A CL2009000920 A CL 2009000920A CL 2009000920 A1 CL2009000920 A1 CL 2009000920A1
Authority
CL
Chile
Prior art keywords
dronedarone
prevention
prepare
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
CL2009000920A
Other languages
Spanish (es)
Inventor
Christophe Gaudin
Nacera Hamdani
David Radzik
Eickels Martin Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43806577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000920(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0802127A external-priority patent/FR2930148A1/en
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CL2009000920A1 publication Critical patent/CL2009000920A1/en

Links

Abstract

Composición farmacéutica de una dosis eficaz de dronedarona o sus sales; artículo de fabricación; un envase; y uso para la prevención de la mortalidad y/o hospitalizaciones cardiovasculares.Pharmaceutical composition of an effective dose of dronedarone or its salts; article of manufacture; a container; and use for the prevention of cardiovascular mortality and / or hospitalizations.

CL2009000920A 2008-04-17 2009-04-16 Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations. CL2009000920A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0802127A FR2930148A1 (en) 2008-04-17 2008-04-17 Use of dronedarone to prepare medicament to prevent mortality and/or cardiovascular hospitalizations in patients having e.g. history of atrial fibrillation/atrial flutter, cerebrovascular accident and non-rheumatic valvular heart disease
US4599508P 2008-04-18 2008-04-18
US6025708P 2008-06-10 2008-06-10
FR0803208 2008-06-10
EP09290095 2009-02-11

Publications (1)

Publication Number Publication Date
CL2009000920A1 true CL2009000920A1 (en) 2010-09-21

Family

ID=43806577

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000920A CL2009000920A1 (en) 2008-04-17 2009-04-16 Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.

Country Status (2)

Country Link
CL (1) CL2009000920A1 (en)
CO (1) CO6260064A2 (en)

Also Published As

Publication number Publication date
CO6260064A2 (en) 2011-03-22

Similar Documents

Publication Publication Date Title
EA201071204A1 (en) DRONEDARON APPLICATION FOR THE PREPARATION OF A MEDICINE FOR THE APPLICATION IN THE PREVENTION OF HOSPITALIZATION IN THE CARDIOLOGICAL DEPARTMENT OR MORTALITY
ES2551307T3 (en) Inhalation composition containing aclidinium for the treatment of chronic obstructive pulmonary disease
BR112012008317A2 (en) sustained release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
DOP2011000264A (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
EA201490014A1 (en) MODIFIED 4-METHYL-3 - [[4- (3-PYRIDINIL) -2-PYRIMIDINYL] AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL-1-IL) -3- (TRIFTOROMETHYL) FENYL ISOLATED ] BENZAMIDE, SILUBILIZED WITH THE USE OF ORGANIC ACIDS
CO6741203A2 (en) Bicyclo derivatives [3,2,1] octylamide and their uses
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
CL2012000319A1 (en) Use of a pharmaceutical composition comprising treprostinil for the preparation of a medicament for the treatment or prevention of a condition associated with cystic fibrosis.
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
PE20100050A1 (en) PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
ECSP10010553A (en) USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
AR090073A1 (en) N-ETIL-N-PHENYL-1,2-DIHIDRO-4,5-DI-HYDROXI-1-METHYL-2-OXO-3-CHINOLINACARBOXAMIDE, ITS PREPARATION AND USES
UY32299A (en) LIQUID PHARMACEUTICAL COMPOSITIONS
CY1116012T1 (en) TYRAZOLI COMPOUNDS AS TOY CRTH2 COMPETITORS
UY31887A (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVERSION
AR088497A1 (en) PHARMACEUTICAL COMPOSITIONS OF COMBINATIONS OF INHIBITORS OF DIPEPTIDIL PEPTIDASE 4 WITH ATORVASTATIN
CL2009000920A1 (en) Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.
ECSP11011212A (en) NEW ASSOCIATION OF ACTIVE INGREDIENTS CONTAINING AN ANTI-INFLAMMATORY, NON-STEROID DRUG AND A COLCHICOSIDE DERIVATIVE
CL2008003584A1 (en) Use of 10 - [(3r) -1-azabicyclo] oct-3-ylmethyl] -10-h-phenothiazine, or one of its pharmaceutically acceptable salts for the preparation of a useful medicine to prevent or treat obstructive bronchopneumopathy.
CL2008000374A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A POWDER FOR ORAL SUSPENSION OF TACROLIMUS OR ONE OF ITS SALTS, HYDRATES OR SOLVATOS AND EXCIPIENTS PHARMACEUTICALLY ACCEPTABLE; PROCEDURE FOR PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION; AND USE FOR PREVE
ECSP10010540A (en) USE OF DRONEDARONA FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY
CR11721A (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY